The registration, importation and distribution of all heartburn medication containing ranitidine has been suspended in the UAE.
According to the Ministry of Health and Prevention (MoHAP), a circular was issued to health facilities and practitioners informing them about the move.
The decision is based on the recommendations of the US Food and Drug Administration (FDA) and other regulatory bodies regarding a possible contamination of the medicine with an impurity which is classified as potentially carcinogenic.
The Ministry says those wishing to stop taking medicine with ranitidine should consult a healthcare professional for a replacement.

UAE announces suspension of Iranian airlines' flights
10 million meals for Gaza in tribute to late Sheikh Ahmed bin Rashid
UAE steps up winter relief efforts for Gaza families
Sheikh Abdullah meets President of Ecuador on UNGA81 sidelines
Dubai Police trains school bus drivers and supervisors on student safety